UTAH MEDICAL PRODUCTS INC UTMD

election_required = True...NTS ALL OF THE SHARES I OWN? Odd lots are not subject to proration. That means all properly tendered odd lots will be purchased in entirety without proration in the event that more shares are tendered than UTMD purchases. To properly tender odd lots, you must complete the section entitled “Odd Lots” in the Letter of Transmittal. See Section 1. WILL I HAVE TO PAY BROKERAGE COMMISSIONS IF I TENDER MY SHARES? If you are a registered shareholder and you tender your shares directly to the depositary, you will not incur any brokerage commissions. If you hold your shares through a broker or a bank, we urge you to consult your broker or bank to determine whether they c...

election_required = True...NTS ALL OF THE SHARES I OWN? Odd lots are not subject to proration. That means all properly tendered odd lots will be purchased in entirety without proration in the event that more shares are tendered than UTMD purchases. To properly tender odd lots, you must complete the section entitled "Odd Lots" in the Letter of Transmittal. See Section 1. WILL I HAVE TO PAY BROKERAGE COMMISSIONS IF I TENDER MY SHARES? If you are a registered shareholder and you tender your shares directly to the depositary, you will not incur any brokerage commissions. If you hold your shares through a broker or a bank, we urge you to consult your broker or bank to determine whether they c...

expiry = 2026-10-07...PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 650,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $75.00 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON TUESDAY, OCTOBER 7, 2026, UNLESS THE OFFER IS EXTENDED. ———————— Utah Medical Products, Inc., a Utah corporation (“UTMD” or the “Company”), hereby invites its stockholders to tender up to 650,000 shares of its Common Stock, par value $.01 per share, to the Company...

expiry = 2026-10-07...PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 650,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $75.00 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON WEDNESDAY, OCTOBER 7, 2026, UNLESS THE OFFER IS EXTENDED. -------------------------------------------- Utah Medical Products, Inc., a Utah corporation ("UTMD" or the "Company"), hereby invites its stockholders to tender up to 650,000 shares of its Common Stock, par...

listed = True...on, to purchase more than 650,000 Shares pursuant to the Offer. See Section 14. The Offer is not conditioned upon any minimum number of Shares being tendered. The Offer is, however, subject to certain other conditions. See Section 6. The Shares are listed and traded on The Nasdaq Stock Market (“Nasdaq”) under the symbol “UTMD.” On September 14, 2026, the last full Nasdaq trading day prior to announcement of the Offer, the closing per Share sales price as reported by Nasdaq was $70.67 per Share. Stockholders are urged to obtain current market quotations for the shares. See Section 7. The Board of Directors of the Company has approved t...

listed = True...on, to purchase more than 650,000 Shares pursuant to the Offer. See Section 14. The Offer is not conditioned upon any minimum number of Shares being tendered. The Offer is, however, subject to certain other conditions. See Section 6. The Shares are listed and traded on The Nasdaq Stock Market ("Nasdaq") under the symbol "UTMD." On September 14, 2026, the last full Nasdaq trading day prior to announcement of the Offer, the closing per Share sales price as reported by Nasdaq was $70.67 per Share. Stockholders are urged to obtain current market quotations for the shares. See Section 7. The Board of Directors of the Company has approved t...

mechanism = FIXEDEX-99.(A)(1)(A) 2 utmd_exa1a.htm FORM OF OFFER TO PURCHASE utmd_exa1a.htm EXHIBIT (a)(1)(A) UTAH MEDICAL PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 650,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $75.00 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON TUESDAY, OCTOBER 7, 2026, UNLESS THE OFFER IS EXTENDED. ———————— Utah Medical Products, Inc., a Utah corporation (“UTMD” or the “Company”), hereby invites its stockholders to tender up to 650,000 shares of its Common Stock, par value $.01 per sh...

mechanism = FIXEDEX-99 2 utah_exa1a.htm EXHIBIT (A)(1)(A) - FORM OF OFFER TO PURCHASE DATED SEPTEMBER 24, 2026. EXHIBIT (a)(1)(A) UTAH MEDICAL PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 650,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $75.00 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON WEDNESDAY, OCTOBER 7, 2026, UNLESS THE OFFER IS EXTENDED. -------------------------------------------- Utah Medical Products, Inc., a Utah corporation ("UTMD" or the "Company"), hereby invites its stockholders to tender up to 650,000 shares of i...

price = USD 75.0...OFFER TO PURCHASE utmd_exa1a.htm EXHIBIT (a)(1)(A) UTAH MEDICAL PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 650,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $75.00 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON TUESDAY, OCTOBER 7, 2026, UNLESS THE OFFER IS EXTENDED. ———————— Utah Medical Products, Inc., a Utah corporation (“UTMD” or t...

price = USD 75.0...URCHASE DATED SEPTEMBER 24, 2026. EXHIBIT (a)(1)(A) UTAH MEDICAL PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 650,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $75.00 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON WEDNESDAY, OCTOBER 7, 2026, UNLESS THE OFFER IS EXTENDED. -------------------------------------------- Utah Medical Products,...

threshold = 100...captioned “Odd Lots” on the Letter of Transmittal. The Company also reserves the right, but will not be obligated, to purchase all Shares duly tendered by any stockholder who tendered all Shares owned beneficially and who, as a result of proration, would then own beneficially an aggregate of fewer than 100 Shares. If the Company exercises this right, it will increase the number of Shares that it is offering to purchase by the number of Shares purchased through the exercise of such right. PRORATION. In the event that proration of tendered Shares is required, the Company will determine the proration factor as soon as practicable following the Expir...

threshold = 100...captioned "Odd Lots" on the Letter of Transmittal. The Company also reserves the right, but will not be obligated, to purchase all Shares duly tendered by any stockholder who tendered all Shares owned beneficially and who, as a result of proration, would then own beneficially an aggregate of fewer than 100 Shares. If the Company exercises this right, it will increase the number of Shares that it is offering to purchase by the number of Shares purchased through the exercise of such right. PRORATION. In the event that proration of tendered Shares is required, the Company will determine the proration factor as soon as practicable following the Expir...

txn_type = TENDER_OFFEREX-99.(A)(1)(A) 2 utmd_exa1a.htm FORM OF OFFER TO PURCHASE utmd_exa1a.htm EXHIBIT (a)(1)(A) UTAH MEDICAL PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 650,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $75.00 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON TUESDAY, OCTOBER 7, 2026, UNLESS THE OFFER IS EXT...

txn_type = TENDER_OFFEREX-99 2 utah_exa1a.htm EXHIBIT (A)(1)(A) - FORM OF OFFER TO PURCHASE DATED SEPTEMBER 24, 2026. EXHIBIT (a)(1)(A) UTAH MEDICAL PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 650,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $75.00 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON WEDNESDAY, OCTOBER 7, 2026, UNLESS THE...